Mahboob U Rahman

Mahboob U Rahman

UNVERIFIED PROFILE

Are you Mahboob U Rahman?   Register this Author

Register author
Mahboob U Rahman

Mahboob U Rahman

Publications by authors named "Mahboob U Rahman"

Are you Mahboob U Rahman?   Register this Author

50Publications

1549Reads

27Profile Views

Effect of golimumab on carotid atherosclerotic disease measures and cardiovascular events in inflammatory arthritides.

J Clin Rheumatol 2014 Jan;20(1):1-10

From the *Allegheny Singer Research Institute, West Penn Allegheny Health System; †Temple University School of Medicine-Pittsburgh Campus, Pittsburgh, PA; ‡Janssen Research & Development, LLC, Spring House, PA; §University of Pennsylvania School of Medicine, Philadelphia, PA; ∥Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom; ¶Department of Neurology and Stroke Center, Hôpital Bichat, Paris, France; #Metroplex Clinical Research Center, Dallas, TX; **Stanford University, Palo Alto, CA; and ††Mayo Clinic College of Medicine, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000053DOI Listing
January 2014

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.

Ann Rheum Dis 2013 Sep 19;72(9):1481-7. Epub 2012 Sep 19.

Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2012-201836DOI Listing
September 2013

Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials.

Arthritis Care Res (Hoboken) 2013 Feb;65(2):309-13

Janssen Research & Development, LLC, Spring House, and University of Pennsylvania School of Medicine, Philadelphia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.21788DOI Listing
February 2013

Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.

Ann Rheum Dis 2011 Nov 21;70(11):1968-74. Epub 2011 Jul 21.

Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK.

View Article

Download full-text PDF

Source
http://ard.bmj.com/cgi/doi/10.1136/ard.2010.146068
Publisher Site
http://dx.doi.org/10.1136/ard.2010.146068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184239PMC
November 2011

Population approach for exposure-response modeling of golimumab in patients with rheumatoid arthritis.

J Clin Pharmacol 2011 May 9;51(5):639-48. Epub 2010 Jul 9.

Pharmacokinetics, Modeling & Simulation, Biologics Clinical Pharmacology, Centocor Research and Development, 200 Great Valley Parkway, Malvern, PA 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270010372520DOI Listing
May 2011

Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease.

Arthritis Care Res (Hoboken) 2011 Apr;63(4):512-21

University of Pittsburgh, School of Nursing, Pittsburgh, Pennsylvania 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.20414DOI Listing
April 2011

Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: a rare adverse event?

Rheumatology (Oxford) 2010 Sep 19;49(9):1785-7. Epub 2010 Apr 19.

Department of Rheumatology, Immunology and Allergy, Christchurch Hospital, Christchurch, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keq101DOI Listing
September 2010

A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate.

J Pharmacokinet Pharmacodyn 2010 Aug 16;37(4):309-21. Epub 2010 Jul 16.

Pharmacokinetics, Modeling and Simulation, Biologics Clinical Pharmacology, Centocor Research and Development, Inc., Malvern, PA 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10928-010-9162-4DOI Listing
August 2010

Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study.

Ann Rheum Dis 2010 Jun 5;69(6):1129-35. Epub 2010 May 5.

University of Toronto and Mount Sinai Hospital, 60 Murray Street, 2nd Floor, Room 2-006, Toronto, Ontario M5G 1X5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ard.2009.116319DOI Listing
June 2010

Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.

Core Evid 2010 Jun 15;4:159-70. Epub 2010 Jun 15.

Division of Rheumatology, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA, USA;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899784PMC
http://dx.doi.org/10.2147/ce.s6000DOI Listing
June 2010

Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group).

J Rheumatol 2009 Oct 14;36(10):2335-41. Epub 2009 Aug 14.

Division of Rheumatology, Johns Hopkins University, 5200 Eastern Avenue, Mason Lord Center Tower, Room 404, Baltimore, MD 21224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.090369DOI Listing
October 2009

Association of anemia and physical disability among patients with rheumatoid arthritis.

J Rheumatol 2007 Nov 15;34(11):2177-82. Epub 2007 Oct 15.

Centocor Research and Development Inc., 200 Great Valley Parkway, Malvern, PA 19355, USA.

View Article

Download full-text PDF

Source
November 2007

Glucocorticoid use, other associated factors, and the risk of tuberculosis.

Arthritis Rheum 2006 Feb;55(1):19-26

Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21705DOI Listing
February 2006

Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.

Arthritis Rheum 2005 Jun;53(3):337-42

Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21179DOI Listing
June 2005

Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification.

Proc Natl Acad Sci U S A 2004 Dec 24;101(49):17192-7. Epub 2004 Nov 24.

Center for Immunology and Inflammatory Diseases, Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Building 149, 13th Street, Room 8301, Boston, MA 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0407788101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC535367PMC
December 2004